Abstract Background Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic
neoplasms. About 40–80% of patients with PNET are metastatic at presentation, usually …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) originate from
neuroendocrine cells in the gastrointestinal tract. They are heterogeneous, and though …

Neuroendocrine neoplasms are diverse in terms of sites of origin, functional status, and
degrees of aggressiveness. This review will introduce some of the common features of …

Pancreatic neuroendocrine tumors (PanNETs) are a rare tumor entity with largely
unpredictable progression and increasing incidence in developed countries. Molecular …

Pancreatic neuroendocrine neoplasms (PNENs) represent 10% of all pancreatic tumors by
prevalence. Their incidence has reportedly increased over recent decades in parallel with …

Neuroendocrine tumors (NETs) represent a large and heterogeneous group of malignancies
with various biological and clinical characteristics, depending on the site of origin and the …

Introduction: Dysregulation of the mechanistic target of rapamycin complex 1 (mTORC1)-
dependent pathways in pancreatic neuroendocrine neoplasms (PanNENs) underlies the …

Pancreatic neuroendocrine tumors (PNETs) are a rare and heterogeneous group of
neoplasia and differ in their clinical presentation, behavior, and prognosis based on both …

Digestive neuroendocrine neoplasms (DNENs) have an incidence of 2.39 per 100,000
inhabitants per year, and a prevalence of 35 cases per 100,000; the gap between these …

OBJECTIVE. The objective of this study was to identify imaging characteristics in patients
with known pancreatic neuroendocrine tumors (PanNETs) that predict the alternative …